SLC6A3 and hyperinsulinemic hypoglycemia, familial, 4: Furthermore, we explored the effectiveness of a newly developed targeted combinatorial Slc6a3 gene therapy strategy that resulted in the selective and robust expression of functional DAT in dopaminergic neurons, leading to efficacious recovery of major neurochemical, molecular and behavioral phenotypes related to DAT deficiency.